Actively Recruiting
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Led by National Cheng-Kung University Hospital · Updated on 2025-01-01
30
Participants Needed
1
Research Sites
162 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with an myofascial trigger point (MTrP) in their upper trapezius will be divided into three groups: Group A receiving MTrP injection with normal saline (control group), Group B with hypo-osmolar dextrose (5% dextrose), and Group C with hyper-osmolar dextrose (15% dextrose). Clinical outcomes and morphological changes will be measured before the injection, one hour after, one week after, two weeks after, and one month after the injection to delineate the therapeutic effects of dextrose injection for an MTrP.
CONDITIONS
Official Title
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 20 years or older
- Able to communicate freely
- Diagnosed with myofascial pain syndrome (MPS) with a definite myofascial trigger point in the neck base or upper back (upper trapezius muscle), identified by: a localized tender spot in a palpable taut muscle band, recognized pain when the spot is pressed, and consistent referred pain
- Symptoms of myofascial pain syndrome lasting more than 3 weeks
You will not qualify if you...
- Acute or serious medical problems
- Cognitive impairment or psychiatric disorder
- Bleeding disorders or coagulopathy
- Taking anticoagulation or antithrombolytic medication
- Sensory deficiency over the body area where trigger points are located
- Infection with hepatitis B or acquired immunodeficiency syndrome
- Malignancy
- Pregnant or likely to be pregnant
- Diabetes mellitus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of physical Medicine and Rehabilitation, National Cheng Kung University Hospital
Tainan, Taiwan, 704
Actively Recruiting
Research Team
T
Ta-Shen Kuan, M.D., M.S.
CONTACT
Y
Yao-Hong Guo, M.D., M.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here